Genenta Science S.p.A. (GNTA) Fair Value 2026

GNTA · Conglomerates ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.0 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (26/100)

Quick Summary — As of 2026-10-07, Genenta Science S.p.A. (GNTA) trades at $0.78. QOC: 5.0/10. Value Trap Risk: 26/100 (LOW). 0/13 models active.

Key Facts

Ticker
GNTA
Price
$0.78
Quality Score
5.0/10
Value Trap Risk
26/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 5.0/10 signals weak fundamentals

What Fair Value Does Each Model Give GNTA?

0 Intrinsic Value Models vs. Current Price ($0.78)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Genenta Science S.p.A. (GNTA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Genenta Science S.p.A. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About GNTA?

0 of 13 models are currently active for GNTA. See which stocks rank higher →

How Does GNTA Rank in Conglomerates?

Among 31 Conglomerates stocks, GNTA ranks #23 by Quality of Company score. CirclFi's QOC score of 5.0/10 evaluates 32 fundamental signals. A score of 5.0 reflects mixed fundamentals.

Genenta Science S.p.A.'s positioning within the Conglomerates segment means that order backlog depth plays an outsized role in fundamental analysis. The sector's unique characteristics — including infrastructure spending cycle — shape both the opportunity set and risk profile.

Is GNTA a Value Trap?

CirclFi's Value Trap algorithm assigns GNTA a score of 26/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Genenta Science S.p.A.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Genenta Science S.p.A. earns a quality score of 5.0/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every GNTA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Genenta Science S.p.A. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Conglomerates Stocks Should You Also Analyze?

11 related Conglomerates stocks with 13-model coverage

GPUSHyperscale Data, Inc.QOC 5.1FIPFTAI Infrastructure Inc.QOC 5.0CIRXCirTran CorporationQOC 5.2PLAGPlanet Green Holdings Corp.QOC 4.8TUSKMammoth Energy Services, Inc.QOC 5.2ATVKGlobalTek Ventures, Inc.QOC 4.8MAMKMaxsMaking Inc.QOC 2.7GHCGraham Holdings CompanyQOC 7.8CODICompass DiversifiedQOC 6.2VMIValmont Industries, Inc.QOC 9.0OTTROtter Tail CorporationQOC 8.6

Read investment analysis: GPUS · FIP · CIRX · PLAG · TUSK · ATVK · MAMK · GHC · CODI · VMI · OTTR

Which Other Stocks Have a Similar Quality Score to GNTA?

7 companies across all industries closest to GNTA’s Quality of Company score of 5.0/10.

CNICanadian National Railway CompanyQOC 5.0DFSCDEFSEC Technologies Inc.QOC 5.0CRVOCervoMed Inc.QOC 5.0PMVPPMV Pharmaceuticals, Inc.QOC 5.0OZBelpointe PREP, LLCQOC 5.0XXII22nd Century Group, Inc.QOC 5.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CNI · DFSC · CRVO · PMVP · OZ · XXII · NVDA

What Else Do Investors Ask About Genenta Science S.p.A.’s Valuation?

What is Genenta Science S.p.A.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Genenta Science S.p.A. (GNTA). The Quality of Company score is 5.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is GNTA overvalued or undervalued right now?

At $0.78, 0 of 0 active models suggest GNTA may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Genenta Science S.p.A.'s business model in Conglomerates.

What does a Quality of Company score of 5.0 mean for GNTA?

Genenta Science S.p.A.'s QOC of 5.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on GNTA?

CirclFi analyzes GNTA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is GNTA a value trap in 2026?

Genenta Science S.p.A.'s Value Trap score is 26/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Genenta Science S.p.A. (GNTA) a Quality of Company score of 5.0/10 across 32 fundamental signals as of 2026-10-07.” Source: circlfi.com/stock/GNTA/ · Methodology
Primary sources for this GNTA valuation
  • Financial statements: Genenta Science S.p.A. 10-K and 10-Q filings on SEC EDGAR (CIK 0001838716) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for GNTA as of ; valuations recomputed .